Volume 31, Number 4—April 2025
Research
Carbapenem-Resistant, Virulence Plasmid–Harboring Klebsiella pneumoniae, United States
Table 3
Antimicrobial resistance of isolates in study of carbapenem-resistant, virulence plasmid–harboring Klebsiella pneumoniae isolates, United States*
Drug | Isolate |
|||||
---|---|---|---|---|---|---|
ARLG-4622 | ARLG-3254 | ARLG-4744 | ARLG-7683 | ARLG-3484 | ARLG-4720 | |
Aztreonam | R | R | R | R | R | R |
Ceftriaxone | R | R | R | R | R | R |
Ceftazidime | R | R | R | R | R | R |
Cefiderocol | S | S | S | ND | S | S |
Ertapenem | R | R | R | R | R | R |
Imipenem | R | R | S | S | R | R |
Meropenem | R | R | S | S | R | R |
Ciprofloxacin | R | S | R | R | R | R |
Levofloxacin | R | S | R | R | R | R |
Fosfomycin | S | S | R | R | S | R |
Trimethoprim/sulfamethoxazole | S | R | R | R | R | R |
Colistin | I | I | I | I | R | R |
Piperacillin/tazobactam | R | R | R | I | R | R |
Meropenem/vaborbactam | S | S | S | S | R | R |
Ceftazdimie/avibactam | S | S | S | S | S | S |
*I, intermediate; ND, not determined; R, resistant; S, susceptible.
Page created: February 18, 2025
Page updated: March 24, 2025
Page reviewed: March 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.